Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

217
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
97.55(c) 97.75(c) 97.45(c) 98.15(c) 97.45(c) Last
5 982 556 8 521 305 10 232 353 10 689 542 7 890 755 Volume
+1.30% +0.21% -0.31% +0.72% -0.71% Change
More quotes
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
02/27 | 04:00amShareholder meeting
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 53 826 M
EBIT 2015 13 890 M
Net income 2015 10 544 M
Debt 2015 6 076 M
Yield 2015 2,82%
Sales 2016 55 083 M
EBIT 2016 14 201 M
Net income 2016 11 483 M
Debt 2016 3 719 M
Yield 2016 3,01%
PER 2015 21,35
PER 2016 21,48
EV / Sales 2015 5,26x
EV / Sales 2016 5,09x
Capitalization 276 783 M
More Financials
Latest news on NOVARTIS AG
12:36a OPHTHOTECH : Releases Fourth Quarter and Full Year 2014 Financial Results
02/27 NOVARTIS : Positive phase II data highlights benefits of Alcon's RTH258 for pati..
02/27 NOVARTIS : Competition Commission of Pakistan approves acquisition of global vac..
02/27 NOVARTIS : Competition Commission of Pakistan approves acquisition of global vac..
02/27DJNOVARTIS : Japan Ordered to Shut Down for Failure to Report Side Effects
02/27 NOVARTIS : shareholders approve all resolutions proposed by Board of Directors
02/27 NOVARTIS : lung cancer drug Zykadia® recommended for EU approval in patients wit..
02/27 NOVARTIS : Japan unit ordered to suspend business for 15 days
More news
Sector news Pharmaceuticals - NEC
02/27 JOHNSON & JOHNSON : Announces Formation of New Health and Wellness Platform Desi..
02/27 ABBOTT LABORATORIES : Mylan closes $5.3B tax-lowering deal with Abbott Labs
02/27 OPKO HEALTH : reports 4Q loss
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF